13F Filings History of CHIRON CAPITAL MANAGEMENT, LLC

Latest 13F report
Q3 2025 - 14 Nov 2025
Value $
$116,774,115
Signature - Title
Michelle Eldridge - SR. COMPLIANCE OFFICER
Location
Tallahassee, FL
Summary
This page shows a list of all the recent 13F filings made by CHIRON CAPITAL MANAGEMENT, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. CHIRON CAPITAL MANAGEMENT, LLC reported 122 stock holdings with total value $116,774,115 as of Q3 2025. Top holdings included BMY, XBI, NVDA, ADBE, and NKE.

Notify me when CHIRON CAPITAL MANAGEMENT, LLC files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q3 2025 122 $116,774,115 +$10,400,952 -$14,353,641 -$3,952,689 BMY, XBI, NVDA, ADBE, NKE 13F-HR 14 Nov 2025, 11:31
Q2 2025 119 $114,936,841 +$17,530,816 -$9,497,702 +$8,033,114 BMY, XBI, ADBE, NKE, UPS 13F-HR 11 Aug 2025, 12:08
Q1 2025 114 $110,040,856 +$22,561,253 -$19,590,400 +$2,970,853 BMY, XBI, CCI, NKE, AFL 13F-HR 15 May 2025, 16:37
Q4 2024 113 $105,940,569 +$12,336,853 -$19,041,867 -$6,705,014 BMY, XBI, AAPL, AFL, EPD 13F-HR 13 Feb 2025, 12:17
Q3 2024 119 $112,986,954 +$8,033,266 -$11,385,159 -$3,351,893 BMY, XBI, NKE, AFL, CVS 13F-HR 14 Nov 2024, 09:51
Q2 2024 113 $104,749,679 +$15,071,791 -$11,616,480 +$3,455,311 BMY, XBI, GILD, CVS, NKE 13F-HR 08 Aug 2024, 11:55
Q1 2024 108 $110,103,346 +$12,293,277 -$22,729,558 -$10,436,281 BMY, XBI, EPD, AFL, PFE 13F-HR 10 May 2024, 16:31
Q4 2023 117 $114,947,482 +$7,069,109 -$15,724,908 -$8,655,799 BMY, XBI, CVS, EPD, AFL 13F-HR 12 Feb 2024, 15:36
Q3 2023 112 $116,255,371 +$17,655,470 -$20,255,229 -$2,599,759 BMY, XBI, T, XLK, CVS 13F-HR 14 Nov 2023, 14:07
Q2 2023 115 $126,277,780 +$6,141,748 -$26,203,510 -$20,061,762 BMY, XBI, FDN, XLK, T 13F-HR 27 Jul 2023, 17:19
Q1 2023 124 $143,846,798 +$9,892,691 -$16,038,271 -$6,145,580 BMY, XBI, FDN, XLK, T 13F-HR 21 Apr 2023, 13:49
Q4 2022 124 $143,789,353 +$8,123,550 -$23,658,353 -$15,534,803 BMY, XBI, FDN, XLK, T 13F-HR 23 Jan 2023, 14:19
Q3 2022 119 $148,819,000 +$10,784,603 -$10,094,119 +$690,484 BMY, XBI, FDN, GILD, XLK 13F-HR 13 Oct 2022, 12:40
Q2 2022 127 $158,518,000 +$29,913,579 -$15,850,384 +$14,063,195 BMY, XBI, FDN, GILD, XLK 13F-HR 25 Jul 2022, 13:47
Q1 2022 123 $157,961,000 +$35,038,110 -$19,418,776 +$15,619,334 BMY, XBI, T, GILD, INTC 13F-HR 18 Apr 2022, 16:21
Q4 2021 109 $138,521,000 +$11,262,779 -$13,979,883 -$2,717,104 BMY, GILD, XBI, PFE, T 13F-HR 18 Jan 2022, 15:26
Q3 2021 101 $137,107,000 +$31,349,428 -$7,019,392 +$24,330,036 BMY, GILD, T, XBI, PFE 13F-HR 21 Oct 2021, 10:43
Q2 2021 79 $120,025,000 +$16,481,029 -$20,248,892 -$3,767,863 BMY, GILD, PFE, T, SPLK 13F-HR 20 Jul 2021, 13:53
Q1 2021 72 $117,835,000 +$12,647,661 -$23,920,662 -$11,273,001 BMY, GILD, PFE, CVS, XLE 13F-HR 18 May 2021, 11:34
Q4 2020 78 $121,383,000 +$7,310,110 -$19,700,122 -$12,390,012 BMY, GILD, XLF, INTC, XLE 13F-HR 05 Mar 2021, 16:15
Q3 2020 491 $124,118,000 $0 $0 $0 BMY, GILD, XLF, XLE, PFE 13F-HR 19 Nov 2020, 16:37